title: Effect of enteropeptidase on survival of cultured hippocampal neurons under conditions of glutamate toxicity.
abstract: The effects of full-size bovine enteropeptidase (BEK) and of human recombinant light chain enteropeptidase (L-HEP) on survival of cultured hippocampal neurons were studied under conditions of glutamate excitotoxicity. Low concentrations of L-HEP or BEK (0.1-1 and 0.1-0.5 nM, respectively) protected hippocampal neurons against the death caused by 100 µM glutamate. Using the PAR1 (proteinase-activated receptor) antagonist SCH 79797, we revealed a PAR1-dependent mechanism of neuroprotective action of low concentrations of enteropeptidase. The protective effect of full-size enteropeptidase was not observed at the concentrations of 1 and 10 nM; moreover, 10 nM of BEK caused death of 88.9% of the neurons, which significantly exceeded the cell death caused by glutamate (31.9%). Under conditions of glutamate cytotoxicity the survival of neurons was 26.8% higher even in the presence of 10 nM of L-HEP than in the presence of 10 nM BEK. Pretreatment of cells with 10 nM of either form of enteropeptidase abolished the protective effect of 10 nM thrombin under glutamate cytotoxicity. High concentrations of BEK and L-HEP caused the death of neurons mainly through necrosis.
authors.affiliation: Faculty of Biology, Lomonosov Moscow State University, Moscow, 119991, Russia.
authors.forename: A M
authors.initials: AM
authors.lastname: Makarova
authors.forename: L R
authors.initials: LR
authors.lastname: Gorbacheva
authors.forename: I V
authors.initials: IV
authors.lastname: Savinkova
authors.forename: A G
authors.initials: AG
authors.lastname: Mikhailova
authors.forename: L D
authors.initials: LD
authors.lastname: Rumsh
authors.forename: V G
authors.initials: VG
authors.lastname: Pinelis
authors.forename: S M
authors.initials: SM
authors.lastname: Strukova
mesh_terms: D000818:Animals; D002417:Cattle; D002470:Cell Survival; D002478:Cells, Cultured; D004765:Enteropeptidase / Q000235:genetics / Q000378:metabolism*; D018698:Glutamic Acid / Q000633:toxicity*; D006624:Hippocampus / Q000166:cytology*; D006801:Humans; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D011758:Pyrroles / Q000494:pharmacology; D011799:Quinazolines / Q000494:pharmacology; D044463:Receptor, PAR-1 / Q000378:metabolism; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D013917:Thrombin / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors
chemical_list: C415424:N3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3, 2-f)quinazoline-1,3-diamine; D011758:Pyrroles; D011799:Quinazolines; D044463:Receptor, PAR-1; D011994:Recombinant Proteins; D018698:Glutamic Acid; D013917:Thrombin; D004765:Enteropeptidase; D010975:Platelet Aggregation Inhibitors